Daptomycin In Vitro Activity against Methicillin-Resistant Staphylococcus aureus Is Enhanced by d -Cycloserine in a Mechanism Associated with a Decrease in Cell Surface Charge
Author(s) -
Oriol Gasch,
Satish K. Pillai,
Joanna Dakos,
Spiros Miyakis,
Robert C. Moellering,
George M. Eliopoulos
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00799-13
Subject(s) - daptomycin , staphylococcus aureus , microbiology and biotechnology , methicillin resistant staphylococcus aureus , in vitro , antibacterial agent , cycloserine , strain (injury) , chemistry , vancomycin , bacteria , antibiotics , biology , biochemistry , anatomy , genetics
The killing activity of daptomycin against an isogenic pair of daptomycin-susceptible and daptomycin-nonsusceptible (DNS) methicillin-resistant Staphylococcus aureus (MRSA) strains was enhanced by the addition of certain cell wall agents at 1× MIC. However, when high inocula of the DNS strain were used, no significant killing was observed in our experiments. Cytochrome c binding assays revealed d-cycloserine as the only agent associated with a reduction in the cell surface charge for both strains at the concentrations used.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom